Financhill
Back

Enlivex Therapeutics Quote, Financials, Valuation and Earnings

Enlivex Therapeutics Price Quote

$1.60
-0.02 (-1.23%)
(Updated: May 6, 2024 at 6:55 PM ET)

Enlivex Therapeutics Key Stats

Sell
20
Enlivex Therapeutics (ENLV) is a Sell

Day range:
$1.52 - $1.66
52-week range:
$1.15 - $4.59
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.01%

Volume:
45.7K
Avg. volume:
291.7K
1-year change:
-42.14%
Market cap:
$30.5M
Revenue:
$0
EPS:
$-1.56

How Much Does Enlivex Therapeutics Make?

Data Unavailable

Is Enlivex Therapeutics Growing As A Company?

Data Unavailable

Enlivex Therapeutics Stock Price Performance

What Is Enlivex Therapeutics 52-Week High & Low?

Enlivex Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Enlivex Therapeutics?

Is Enlivex Therapeutics Cash Flow Positive?

  • What Is ENLV Cash Flow From Operations?
    Cash flow from operations (TTM) is -$23.5M
  • What Is Enlivex Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $360K
  • What Is Enlivex Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$26M

Enlivex Therapeutics Return On Invested Capital

Data Unavailable

Enlivex Therapeutics Earnings Date & Stock Price

Enlivex Therapeutics Competitors

Enlivex Therapeutics Dividend Yield

Data Unavailable

Enlivex Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -71.43%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 332.1%

Major Shareholders

  • How many ENLV shares are owned by institutional investors?
    317.8K ENLV shares are owned by institutional investors
  • How many ENLV shares are owned by insiders?
    0 ENLV shares are owned by insiders